Literature DB >> 26112989

Cirrhotic Multiorgan Syndrome.

Søren Møller1, Flemming Bendtsen2.   

Abstract

Patients with cirrhosis and portal hypertension are at an increased risk of the development of circulatory dysfunction that may potentially result in multiple organ failure. Apart from the liver, this may involve the heart, lungs, kidneys, the immune system, the adrenal glands, and other organ systems. As the disease progresses, the circulation becomes hyperdynamic, and signs of cardiac, pulmonary, and renal dysfunction are observed, in addition to reduced survival. Infections and an altered cardiac function known as cirrhotic cardiomyopathy may be precipitators for the development of other complications such as hepatorenal syndrome. In patients with chronic organ dysfunction, various precipitating events may induce an acute-on-chronic renal failure and acute-on-chronic liver failure that negatively affect the prognosis. Future research on the pathophysiologic mechanisms of the complications and the precipitating factors is essential to understand the basics of the treatment of these challenging conditions. The aim of the present review is to focus on the development and precipitating factors of various organ failures in patients with decompensated cirrhosis.

Entities:  

Keywords:  Cirrhosis; Cirrhotic cardiomyopathy; Hyperdynamic syndrome; Portal hypertension; Pulmonary dysfunction

Mesh:

Year:  2015        PMID: 26112989     DOI: 10.1007/s10620-015-3752-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  180 in total

Review 1.  Cardiovascular dysfunction in cirrhosis. Pathophysiological evidence of a cirrhotic cardiomyopathy.

Authors:  S Møller; J H Henriksen
Journal:  Scand J Gastroenterol       Date:  2001-08       Impact factor: 2.423

Review 2.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

Review 3.  Management of critically-ill cirrhotic patients.

Authors:  Pere Ginès; Javier Fernández; François Durand; Faouzi Saliba
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

Review 4.  The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.

Authors:  Thomas D Boyer; Ziv J Haskal
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

Review 5.  Pathological bacterial translocation in liver cirrhosis.

Authors:  Reiner Wiest; Melissa Lawson; Markus Geuking
Journal:  J Hepatol       Date:  2013-08-28       Impact factor: 25.083

Review 6.  Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice.

Authors:  Paolo Angeli; Pere Gines
Journal:  J Hepatol       Date:  2012-06-26       Impact factor: 25.083

Review 7.  Portopulmonary hypertension.

Authors:  Michael J Krowka
Journal:  Semin Respir Crit Care Med       Date:  2012-03-23       Impact factor: 3.119

8.  Changes in cardiovagal baroreflex sensitivity are related to increased ventricular mass in patients with liver cirrhosis.

Authors:  Jun-Gol Song; Young-Kug Kim; Won-Jung Shin; Gyu-Sam Hwang
Journal:  Circ J       Date:  2012-08-28       Impact factor: 2.993

9.  Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging.

Authors:  Konstantin Kazankov; Peter Holland-Fischer; Niels H Andersen; Peter Torp; Erik Sloth; Niels K Aagaard; Hendrik Vilstrup
Journal:  Liver Int       Date:  2011-02-15       Impact factor: 5.828

10.  Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study.

Authors:  Francisco Sampaio; Joana Pimenta; Nuno Bettencourt; Ricardo Fontes-Carvalho; Ana P Silva; João Valente; Paulo Bettencourt; José Fraga; Vasco Gama
Journal:  Liver Int       Date:  2013-04-25       Impact factor: 5.828

View more
  9 in total

Review 1.  Cirrhotic Cardiomyopathy: A New Clinical Phenotype.

Authors:  Luis Otávio Cardoso Mocarzel; Mariana Macedo Rossi; Bruna de Mello Miliosse; Pedro Gemal Lanzieri; Ronaldo Altenburg Gismondi
Journal:  Arq Bras Cardiol       Date:  2017-06       Impact factor: 2.000

Review 2.  Diastolic dysfunction in cirrhosis.

Authors:  Søren Møller; Signe Wiese; Hanne Halgreen; Jens D Hove
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

3.  Diagnosis and Management of Cirrhotic Cardiomyopathy.

Authors:  Harpreet Kaur; Madhumita Premkumar
Journal:  J Clin Exp Hepatol       Date:  2021-08-21

4.  Cirrhotic Cardiomyopathy: Another Case of a Successful Approach to Treatment of Hepatorenal Syndrome.

Authors:  Luis Otávio Mocarzel; Jessica Bicca; Luiza Jarske; Thamires Oliveira; Pedro Lanzieri; Ronaldo Gismondi; Mario Luiz Ribeiro
Journal:  Case Rep Gastroenterol       Date:  2016-10-10

Review 5.  Fluid balance concepts in medicine: Principles and practice.

Authors:  Maria-Eleni Roumelioti; Robert H Glew; Zeid J Khitan; Helbert Rondon-Berrios; Christos P Argyropoulos; Deepak Malhotra; Dominic S Raj; Emmanuel I Agaba; Mark Rohrscheib; Glen H Murata; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2018-01-06

6.  Skin temperature variability is an independent predictor of survival in patients with cirrhosis.

Authors:  Matteo Bottaro; Noor-Ul-Hoda Abid; Ilias El-Azizi; Joseph Hallett; Anita Koranteng; Chiara Formentin; Sara Montagnese; Ali R Mani
Journal:  Physiol Rep       Date:  2020-06

7.  Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis.

Authors:  Emilie Garnæs; Christian Mortensen; Lise Hobolth; Ove Andersen; Jan Nehlin; Søren Møller
Journal:  PLoS One       Date:  2019-08-29       Impact factor: 3.240

Review 8.  Cirrhotic Cardiomyopathy: The Interplay Between Liver and Cardiac Muscle. How Does the Cardiovascular System React When the Liver is Diseased?

Authors:  Spyros P Dourakis; Eleni Geladari; Charalampia Geladari; Natalia Vallianou
Journal:  Curr Cardiol Rev       Date:  2021

Review 9.  Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients.

Authors:  Aritz Perez Ruiz de Garibay; Andreas Kortgen; Julia Leonhardt; Alexander Zipprich; Michael Bauer
Journal:  Crit Care       Date:  2022-09-26       Impact factor: 19.334

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.